Skip to Content
Exit Menu
Dr Su-Ling Li

Dr Su-Ling Li
Reader - Biosciences

Research supervision

PhD Students supervised or currently Supervising

- Total 12 PhD students successfully graduated under my first supervision:

1. Kajsa Paulsson (finished 2001) - Quality control of MHC class I antigen presentation (1st supervision)

2. Anderson Per (finished 2003) - Orchestration of the signalling network in T cells (1st supervision)

3. Li Li (finished 2004) - SOCS family and its function in regulation of intracellular signalling(1st supervision).

4. Elisavet Primpidou (finished 2007) - Development of peptide-edited microsome vaccine (1st supervision)

5. Sabah Khalid (finished 2008) - Microarray Bioinformatics (1st supervision)

6. Mohsin Khan (finished 2009) - Immuno-Bioinformatics (1st supervision)

7. Mengya Liu ( finished 2011)- Nano-APC deliver antigen, IL2 and costimulatory molecules to antigen specific T cells and activate viral specific T cells in chronic infections (1st supervision)

8. Emma Ghaffari (finished 2013) - Early Growth Response Genes -2 and -3 are essential for optimal immune response -To study T Cell Receptor Signalling and Autoimmune disease in EGR-2 and EGR-3 deficient mice

9. Punamdip Kaur Bhullar (finished 2013) - Early growth response genes 2 and/or 3 are essential for the control of inflammation and for the regulation of tumour suppressor genes (1st supervision)

10. Ane Theodora Ogbe (finished 2015) - Early Growth Response genes 2 and 3 play a role in chronic inflammation pathology and are essential for the differentiation of T follicular helper cells (1st supervision)

11. Becky Omodho (finished 2016) - Early growth response gene (Egr) 2 and 3 control inflammatory responses of tolerant T cells (1st supervision)

12. Randeep Singh (finished 2017) -Early Growth Response genes 2 and 3 are potent inhibitors of T-bet function for Interferon Gamma production in T cells (1st supervision)

Nima Taefehshokr (currently under my supervising ) – Regulation of Egr2/3 gene expression and its role in tumor environment (1st supervision)